Microbes and TNF drive colitis in the absence of innate lymphoid cells

Innate lymphoid cells (ILCs) are critical sources of cytokines necessary for intestinal homeostasis in immunocompetent conditions, yet their necessity in innate colitis remains unclear. Using a model of inflammatory bowel disease (IBD) in mice lacking adaptive immunity, we investigated whether ILCs are required for innate colitis. Interleukin-15 receptor alpha-deficient mice lacked intestinal ILC1 and natural killer (NK) cells, but innate colitis in these mice was not diminished. Deletion of IL-2 receptor gamma chain, which ablates all ILCs and NK cells, also did not prevent innate colitis. Antibiotic treatment of mice lacking all ILCs prevented colitis. Similarly, TNF deficiency prevented colitis in the absence of all ILCs, demonstrating that TNF is essential for microbe-driven innate colitis in the absence of ILCs. These findings reveal that ILCs are redundant for innate colitis. Studies of innate colitis in the absence of ILCs may help understand mechanisms underlying IBD and the effectiveness of anti-TNF therapies.

Authors

Institutions

Publication Details

Journal
iScience
Published
2026-10-27
DOI
https://doi.org/10.1016/j.isci.2026.118000
Primary Topic
IL-33, ST2, and ILC Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microbes and TNF drive colitis in the absence of innate lymphoid cells

Theodore Reed, Arpitha Mysore Rajashekara, Alvaro Torres-Huerta, Eric Bixby et al.
iScience
IL-33, ST2, and ILC Pathways
article

Microbes and TNF drive colitis in the absence of innate lymphoid cells

Theodore Reed, Arpitha Mysore Rajashekara, Alvaro Torres-Huerta, Eric Bixby, Antonia M. Boger-May, Madeleine E. Frech, David L. Boone, Lauren C. Mayer, Katelyn Ruley-Haase, Morgan Hiller, Kyle Elliot, Annie-Cate Schmidt
article en

Abstract

Innate lymphoid cells (ILCs) are critical sources of cytokines necessary for intestinal homeostasis in immunocompetent conditions, yet their necessity in innate colitis remains unclear. Using a model of inflammatory bowel disease (IBD) in mice lacking adaptive immunity, we investigated whether ILCs are required for innate colitis. Interleukin-15 receptor alpha-deficient mice lacked intestinal ILC1 and natural killer (NK) cells, but innate colitis in these mice was not diminished. Deletion of IL-2 receptor gamma chain, which ablates all ILCs and NK cells, also did not prevent innate colitis. Antibiotic treatment of mice lacking all ILCs prevented colitis. Similarly, TNF deficiency prevented colitis in the absence of all ILCs, demonstrating that TNF is essential for microbe-driven innate colitis in the absence of ILCs. These findings reveal that ILCs are redundant for innate colitis. Studies of innate colitis in the absence of ILCs may help understand mechanisms underlying IBD and the effectiveness of anti-TNF therapies.

iScienceVol. 29(11)
University of Notre Dame (US), Indiana University South Bend (US), Indiana University School of Medicine (US)
Indiana Clinical and Translational Sciences Institute, Mike and Josie Harper Cancer Research Institute, National Institutes of Health, University of Texas MD Anderson Cancer Center, Notre Dame Integrated Imaging Facility, University of Notre Dame, National Institute of Diabetes and Digestive and Kidney Diseases
Good health and well-being
Openalex Percentile: Top 19%
IL-33, ST2, and ILC Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon